IP37-24: Validation of the ePI-FAB Score to Predict Residual Disease Following Cooled Focal Laser Ablation with ProFocalTM in Prostate Cancer

IP37-24: Validation of the ePI-FAB Score to Predict Residual Disease Following Cooled Focal Laser Ablation with ProFocalTM in Prostate Cancer

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
145AB
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!